TY - JOUR
T1 - Review article: Peripheral intravenous catheter insertion in adult patients with difficult intravenous access: A systematic review of assessment instruments, clinical practice guidelines and escalation pathways
AU - Paterson, Rebecca S.
AU - Schults, Jessica A.
AU - Slaughter, Eugene
AU - Cooke, Marie
AU - Ullman, Amanda
AU - Kleidon, Tricia M.
AU - Keijzers, Gerben
AU - Marsh, Nicole
AU - Rickard, Claire M.
N1 - Funding Information:
This research was funded by a National Health and Medical Research Council (NHMRC) Partnership Project Grant (APP1180193). Open access publishing facilitated by The University of Queensland, as part of the Wiley - The University of Queensland agreement via the Council of Australian University Librarians. JAS reports grant funding from Griffith University, Children's Hospital Foundation and investigator-initiated research and educational grants provided to Griffith University by vascular access product manufacturers (Baxter, Becton Dickinson), unrelated to this project. MC reports grant funding from Griffith University, Children's Hospital Foundation, National Health and Medical Research Council (NHMRC), Royal Brisbane and Women's Hospital Foundation, Cancer Council Queensland, Australasian College for Infection Prevention and Control, and investigator-initiated research and educational grants and speaker fees provided to Griffith University by vascular access product manufacturers (Becton Dickinson), unrelated to this project. AU reports fellowships and grants by the NHMRC, employment by Griffith University, grants by the Children's Hospital Foundation, Royal Brisbane and Women's Hospital Foundation, Emergency Medicine Foundation and the Australian College of Critical Care Nursing, and investigator-initiated research grants and speaker fees provided to Griffith University from 3M, Cardinal Health and Becton Dickinson. TMK reports grant funding from Children's Hospital Foundation, Griffith University, NHMRC, Emergency Medicine Foundation and investigator-initiated research grants and speaker fees provided to Griffith University from vascular access product manufacturers 3M Medical, Access Scientific, BD-Bard, Medical Specialties Australia, Smiths Medical, Vygon. GK reports investigator-initiated grant funding from the Gold Coast Hospital Foundation, NHMRC and Emergency Medicine Foundation. NM reports investigator-initiated research grants and speaker fees provided to Griffith University from vascular access product manufacturers (3M, BD-Bard, Cardinal Health, Eloquest Healthcare), unrelated to this project. CMR reports investigator-initiated research grants and speaker fees provided to Griffith University or University of Queensland from vascular access product manufacturers (3M, BD-Bard; Cardinal Health, Eloquest Healthcare), unrelated to this project.
Funding Information:
This research was funded by a National Health and Medical Research Council (NHMRC) Partnership Project Grant (APP1180193). Open access publishing facilitated by The University of Queensland, as part of the Wiley ‐ The University of Queensland agreement via the Council of Australian University Librarians.
Funding Information:
JAS reports grant funding from Griffith University, Children's Hospital Foundation and investigator‐initiated research and educational grants provided to Griffith University by vascular access product manufacturers (Baxter, Becton Dickinson), unrelated to this project. MC reports grant funding from Griffith University, Children's Hospital Foundation, National Health and Medical Research Council (NHMRC), Royal Brisbane and Women's Hospital Foundation, Cancer Council Queensland, Australasian College for Infection Prevention and Control, and investigator‐initiated research and educational grants and speaker fees provided to Griffith University by vascular access product manufacturers (Becton Dickinson), unrelated to this project. AU reports fellowships and grants by the NHMRC, employment by Griffith University, grants by the Children's Hospital Foundation, Royal Brisbane and Women's Hospital Foundation, Emergency Medicine Foundation and the Australian College of Critical Care Nursing, and investigator‐initiated research grants and speaker fees provided to Griffith University from 3M, Cardinal Health and Becton Dickinson. TMK reports grant funding from Children's Hospital Foundation, Griffith University, NHMRC, Emergency Medicine Foundation and investigator‐initiated research grants and speaker fees provided to Griffith University from vascular access product manufacturers 3M Medical, Access Scientific, BD‐Bard, Medical Specialties Australia, Smiths Medical, Vygon. GK reports investigator‐initiated grant funding from the Gold Coast Hospital Foundation, NHMRC and Emergency Medicine Foundation. NM reports investigator‐initiated research grants and speaker fees provided to Griffith University from vascular access product manufacturers (3M, BD‐Bard, Cardinal Health, Eloquest Healthcare), unrelated to this project. CMR reports investigator‐initiated research grants and speaker fees provided to Griffith University or University of Queensland from vascular access product manufacturers (3M, BD‐Bard; Cardinal Health, Eloquest Healthcare), unrelated to this project.
Publisher Copyright:
© 2022 The Authors. Emergency Medicine Australasia published by John Wiley & Sons Australia, Ltd on behalf of Australasian College for Emergency Medicine.
PY - 2022/12
Y1 - 2022/12
N2 - The optimal approach for peripheral intravenous catheter (PIVC) insertion in adult hospitalised patients with difficult intravenous access (DIVA) is unknown. The present study aimed to critically appraise the quality of (i) assessment instruments and (ii) clinical practice guidelines (CPGs) or escalation pathways for identifying and managing patients with DIVA. Cochrane Central Register of Controlled Trials, EBSCO MEDLINE, EMBASE (OVID) and EBSCO CINAHL databases were searched on 22 March 2021. Studies describing a DIVA assessment measure, CPG or escalation pathway for PIVC insertion in adults (≥18 years of age) were included. Data were extracted using a standardised data extraction form including study design, type of resource and reported clinical outcomes. Quality of DIVA assessment instruments were reviewed using the COnsensus-based Standards for the selection of health Measurement Instruments checklist. Methodological quality of CPGs and escalation pathways was assessed using the Appraisal of Guidelines for Research and Evaluation-II (AGREE-II) instrument. Overall, 24 DIVA resources comprising 16 DIVA assessment instruments and nine CPGs or escalation pathways (including one combined assessment instrument and escalation pathway) were identified. Instruments commonly focused on vein visibility and palpability as indicators of DIVA. CPGs and escalation pathways unanimously recommended use of vessel visualisation technology for patients with or suspected of DIVA. Methodological quality of the resources was mixed. Consensus and standardisation of resources to identify DIVA and recommendations for managing patients with DIVA is limited. Adopting consistent, evidence-based CPGs, escalation pathways or DIVA assessment instruments may significantly improve clinical outcomes.
AB - The optimal approach for peripheral intravenous catheter (PIVC) insertion in adult hospitalised patients with difficult intravenous access (DIVA) is unknown. The present study aimed to critically appraise the quality of (i) assessment instruments and (ii) clinical practice guidelines (CPGs) or escalation pathways for identifying and managing patients with DIVA. Cochrane Central Register of Controlled Trials, EBSCO MEDLINE, EMBASE (OVID) and EBSCO CINAHL databases were searched on 22 March 2021. Studies describing a DIVA assessment measure, CPG or escalation pathway for PIVC insertion in adults (≥18 years of age) were included. Data were extracted using a standardised data extraction form including study design, type of resource and reported clinical outcomes. Quality of DIVA assessment instruments were reviewed using the COnsensus-based Standards for the selection of health Measurement Instruments checklist. Methodological quality of CPGs and escalation pathways was assessed using the Appraisal of Guidelines for Research and Evaluation-II (AGREE-II) instrument. Overall, 24 DIVA resources comprising 16 DIVA assessment instruments and nine CPGs or escalation pathways (including one combined assessment instrument and escalation pathway) were identified. Instruments commonly focused on vein visibility and palpability as indicators of DIVA. CPGs and escalation pathways unanimously recommended use of vessel visualisation technology for patients with or suspected of DIVA. Methodological quality of the resources was mixed. Consensus and standardisation of resources to identify DIVA and recommendations for managing patients with DIVA is limited. Adopting consistent, evidence-based CPGs, escalation pathways or DIVA assessment instruments may significantly improve clinical outcomes.
UR - http://www.scopus.com/inward/record.url?scp=85136858106&partnerID=8YFLogxK
U2 - 10.1111/1742-6723.14069
DO - 10.1111/1742-6723.14069
M3 - Review article
C2 - 36038953
AN - SCOPUS:85136858106
SN - 1742-6731
VL - 34
SP - 862
EP - 870
JO - EMA - Emergency Medicine Australasia
JF - EMA - Emergency Medicine Australasia
IS - 6
ER -